Key result
Pediatric cardiovascular drug trials face significant challenges including lack of liquid formulations, poor dose selection, and difficult surrogate endpoints that contribute to trial failures.
Population
Children with cardiac disease
Design
Review
Authors
Loading...
Pediatric cardiology trials often fail to show dose-response or adult efficacy; leaves open need for better designs before practice change.
Pediatric cardiovascular trials face unique challenges including formulation issues, pharmacokinetic integration, and endpoint selection that must be addressed to improve future trial success.
Li et al. (2011) conducted a review in Pediatric cardiovascular disease. Cardiovascular drugs was evaluated. Pediatric cardiovascular drug trials face significant challenges including lack of liquid formulations, poor dose selection, and difficult surrogate endpoints that contribute to trial failures.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: